Education
About Us
Working with TipRanks
Follow Us
Zomedica (ZOMDF)
OTHER OTC:ZOMDF
Total Valuation
Zomedica has a market cap or net worth of $43.61M. The enterprise value is ―.
Market Cap$43.61M
Enterprise Value―
Share Statistics
Zomedica has 979,949,650 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding979,949,650
Owned by Insiders2.29%
Owned by Institutions0.04%
Financial Efficiency
Zomedica’s return on equity (ROE) is -0.14 and return on invested capital (ROIC) is -12.41%.
Return on Equity (ROE)-0.14
Return on Assets (ROA)-0.14
Return on Invested Capital (ROIC)-12.41%
Return on Capital Employed (ROCE)-0.13
Revenue Per Employee174.90K
Profits Per Employee-239.78K
Employee Count144
Asset Turnover0.10
Inventory Turnover1.54
Valuation Ratios
The current PE Ratio of Zomedica is -5.68. Zomedica’s PEG ratio is 0.14.
PE Ratio-5.68
PS Ratio0.00
PB Ratio0.47
Price to Fair Value0.82
Price to FCF-4.85
Price to Operating Cash Flow-4.00
PEG Ratio0.14
Income Statement
In the last 12 months, Zomedica had revenue of 25.19M and earned -34.53M in profits. Earnings per share was -0.04.
Revenue25.19M
Gross Profit17.32M
Operating Income-31.59M
Pretax Income-35.86M
Net Income-34.53M
EBITDA-29.39M
Earnings Per Share (EPS)-0.04
Cash Flow
In the last 12 months, operating cash flow was -23.83M and capital expenditures 4.19M, giving a free cash flow of -19.64M billion.
Operating Cash Flow-23.83M
Free Cash Flow-19.64M
Free Cash Flow per Share-0.02
Dividends & Yields
Zomedica pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.91
52-Week Price Change-73.33%
50-Day Moving Average0.05
200-Day Moving Average0.10
Relative Strength Index (RSI)37.33
Average Volume (3m)1.47M
Important Dates
Zomedica upcoming earnings date is Aug 18, 2025, TBA Not Confirmed.
Last Earnings DateMay 15, 2025
Next Earnings DateAug 18, 2025
Ex-Dividend Date―
Financial Position
Zomedica as a current ratio of 11.06, with Debt / Equity ratio of 1.02%
Current Ratio11.06
Quick Ratio10.49
Debt to Market Cap0.00
Net Debt to EBITDA0.35
Interest Coverage Ratio-180.53
Taxes
In the past 12 months, Zomedica has paid -1.33M in taxes.
Income Tax-1.33M
Effective Tax Rate0.04
Enterprise Valuation
Zomedica EV to EBITDA ratio is -6.33, with an EV/FCF ratio of -9.02.
EV to Sales7.38
EV to EBITDA-6.33
EV to Free Cash Flow-9.02
EV to Operating Cash Flow-11.64
Balance Sheet
Zomedica has $76.88M in cash and marketable securities with $2.08M in debt, giving a net cash position of -$74.80M billion.
Cash & Marketable Securities$76.88M
Total Debt$2.08M
Net Cash-$74.80M
Net Cash Per Share-$0.08
Tangible Book Value Per Share$0.13
Margins
Gross margin is 55.24%, with operating margin of -125.43%, and net profit margin of -137.10%.
Gross Margin55.24%
Operating Margin-125.43%
Pretax Margin-142.38%
Net Profit Margin-137.10%
EBITDA Margin-116.68%
EBIT Margin-141.69%
Analyst Forecast
The average price target for Zomedica is $0.25, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$0.25
Price Target Upside525.00% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast11.33%
EPS Growth Forecast-317.76%